Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q3 FY24 Earnings Presentation
24 slides from Rossari Biotech's earnings presentation, Jan 21, 2024
Slide 1: Cover letter to stock exchanges
January 21, 2024 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor, Plot No. C/1, Rotunda Building, Phiroze Jeejeebhoy Towers ‘G’ Block, Bandra- Kurla Complex Dalal Street, Fort, Mumbai 400001 Bandra East, Mumbai 400 05
Slide 2: Rossari Biotech Limited Q3 & 9M FY24 Results Presentation
Rossari Biotech Limited Q3 & 9M FY24 Results Presentation January 20, 2024
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to b
Slide 4: Q3 FY24 Results Overview
Q3 FY24 Results Overview 3
Slide 5: Q3 FY24 – Key Financial Highlights
Q3 FY24 – Key Financial Highlights Revenue from Operations EBITDA PAT (Rs. In cr) (Rs. In cr) (Rs. In cr) Strong Quarterly Consistent quarterly Revenue Highest quarterly EBITDA Highest quarterly PAT Performance 63.7 63.6 34.4 463.8 483.5 54.2 32.9 389.3 25.7 Q3 FY24 Q2 FY24 Q3 FY23 Q3 FY24 Q2 FY24 Q
Slide 6: Financial Performance Snapshot
Financial Performance Snapshot Revenue (Rs. crore) EBITDA (Rs. crore) PAT (Rs. crore) 223 107 1,483 1,656 183 185 98 97 1,358 80 124 709 FY21 FY22 FY23 9M FY24 FY21 FY22 FY23 9M FY24 FY21 FY22 FY23 9M FY24 • Consistent growth trajectory over the past three years, driven by both organic and inorganic
Slide 7: Management Message
Management Message Commenting on the performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We are pleased to report yet another strong quarter, with revenues and profits showing a significant Y-o-Y increase of 1
Slide 8: Key Developments
Key Developments Update on Capital Expansion Plan In a strategic move towards future readiness, in the last quarter we had announced an expansion of our facility at Dahej, to foray into products related to HPPC in the specialty chemical space, as well as for producing ingredients for our subsidiar
Slide 9: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. crore) Q3 FY24 Q3 FY23 Y-o-Y Shift (%) 9M FY24 9M FY23 Y-o-Y Shift (%) Revenues from Operations 463.8 389.3 19.1% 1,357.8 1,249.4 8.7% Total Expenditure • COGS 323.0 272.4 18.6% 955.2 885.0 7.9% • Employee benefits expense 26.0 24.2 7.4% 78.1 71
Slide 10: Q3 FY24 - Segment-wise Details
Q3 FY24 - Segment-wise Details Segment-wise Revenue Break-up (Rs. crore) Q3 FY24 Q2 FY24 Q3 FY23 355.4 367.1 271.2 83.4 95.9 89.5 25.0 20.5 28.6 HPPC TSC AHN Shift (Y-o-Y) % 31.0% -6.8% -12.6% Shift (Q-o-Q) % -3.2% -13.0% 22.0% Note: 1) All figures, unless mentioned otherwise, are on a consolidated
Slide 11: Q3 FY24 - Financial and Operational Discussions
Q3 FY24 - Financial and Operational Discussions Net Revenue Q3 FY24 Revenues from operations increased by 19% YoY to Rs. 463.8 crore from Rs. 389.3 crore The Company successfully registered significant YoY topline growth during the quarter amidst challenging external conditions o Overall growth wa
Slide 12: Company Overview
Company Overview 11
Slide 13: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 45+ 8* 354,100* 4* 34% 24% cumulative years of Manufacturing MTPA Revenue CAGR % PAT CAGR % experience in the R&D Facilities facilities Capacity Installed (FY19-23) (FY19-23) specialty chemicals industry Rossari – A Specialty-Chemical manufacturer prov
Slide 14: Business Overview
Business Overview One of the leading specialty chemicals manufacturer delivering differentiated & tailor-made solutions across Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health and Nutrition (AHN) businesses HPPC TSC AHN One of the fastest-gr
Slide 15: Strengthening Market Presence
Strengthening Market Presence Growing client base Diversifying of over 1,000 customer base to customers both lower India and concentration risk International Widening Increasingly tapping distribution new segments across network to drive domestic and reach international markets Company’s focus towar
Slide 16: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Located on 8.6 acres of land Manufacturing Fungible manufacturing capabilities for powders, granules and liquids Facility at Facility has a comprehensive range of testing & packaging capabilities Silvassa Effluent treatment facility, with 2,500 MT bulk stora
Slide 17: Strategic Growth Levers
Strategic Growth Levers Augmenting product portfolio with enhanced emphasis on green solutions Increase wallet share across existing customer base while also tapping new customer segments Identifying and developing new niches in product offerings by leveraging R&D capabilities Capitalize on cros
Slide 18: Inorganic Initiatives
Inorganic Initiatives Executed two synergistic acquisitions and one strategic investment in FY 2022 complementing the ethos of Rossari’s business model SF Unitop Chemicals Tristar Intermediates Romakk Chemicals Prominent player in the field of Preservatives, Primarily engaged in the business of manu
Slide 19: Key Synergies from Acquisitions
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Augmented Pooling together Expansion of of related Inorganic presence in Extension of addressable technologies investments Specialty manufacturing domestic and within operational C
Slide 20: Focus on Green & Sustainable Chemical Solutions
Focus on Green & Sustainable Chemical Solutions Specialists in producing environmentally- benign substitutes that replace legacy and harmful products Focus on green, sustainable and cost neutral products Minimizing carbon footprint of manufacturing processes while maximizing customer benefits Aggres
Slide 21: Annexure
ROSSARI making you more competitive Annexure 20
Slide 22: Conference Call Details
Conference Call Details Q3 FY2024 Earnings Conference Call Time 04:00 p.m. IST on Tuesday, January 23, 2024 To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Pre-registration Primary dial-in number + 91 22 62
Slide 23: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a For further information, please contact: Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Ketan Sablok Headquartered at Mumbai, India, the Company operates Ro
Slide 24: Thank you
Thank y#u ‘aking you more competitive